Advanced in vitro exposure systems.

19. Apr. 2021

Product News 04/2021

The new VITROCELL® Millicell Holder

How to use Millicell 24-well Standing Inserts in the VITROCELL® 12 Module Series

The revolutionary new holder system enables for the use of standing inserts in all modules of the VITROCELL® 12 Series for 12-well sized inserts. As an additional advantage, the media com­partment is sealed towards the aerosol exposure head to avoid contact of the test substance with the cell culture media.

VITROCELL® Millicell Holder – How to use Millicell 24-well Standing inserts in the VITROCELL® 12 Module Series

 

Read more

Comments (0) Number of views (260)

3. Mar. 2021

Vitrocell® Leak Tester

Must-have device for aerosol research – easy and efficient leak detection

Regular leak tests are mandatory in aerosol research. A leak caused by a forgotten connection or defective o-ring may have a significant influence on the aerosol exposure process. We recommend to carry out a leak test prior to the experiment and as part of cleaning or service routine.

VITROCELL Application Note

Read more

Comments (0) Number of views (672)

15. Jan. 2021

New Video: VITROCELL Cloud Alpha – Product Family Overview

For virus research, testing of inhaled drugs, chemicals and nanoparticles at the Air/Liquid Interface (ALI). The systems are suitable for nebulized solutions and suspensions.

The VITROCELL® Cloud Alpha series is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines reliable exposure of cell cultures from the respiratory tract with ease of use. The series comprises the Cloud Alpha 6, Cloud Alpha 12, Cloud Alpha 96 and Cloud Alpha MAX – they represent an optimal solution for everyday experiments at the Air/Liquid Interface using 6-well, 12-well, 24-well or 96-sized inserts.

This video showcases available product configurations.

 

Read more

Comments (0) Number of views (1001)

26. Mar. 2020

Screening antiviraler pharmazeutischer Leitwirkstoffe gegen das Coronavirus (COVID-19 / SARS-CoV-2)

VITROCELL in vitro Expositionssysteme für hocheffiziente und realistische Applikation aerosolisierter Medikamente auf menschliche Zellen des Atemtraktes unter physiologischen Bedingungen.

In der Inhalationstherapie werden pharmazeutische Präparate als Aerosole auf Zellen des Atemtraktes im Nasen- oder Lungenbereich appliziert. Zur präklinischen Entwicklung neuer Arzneimittel werden dafür oft kommerziell erhältliche, physiologisch relevante in vitro Zellkulturmodelle des Nasen-, Rachen- oder Lungenepithels verwendet. In jüngster Zeit wurden diese Modelle verfeinert, um SARS-CoV-2 Infektionen nachzuahmen.

VITROCELL Anwendungshinweis.

Read more

Comments (0) Number of views (1207)

15. Jun. 2021

VITROCELL® Cloud Alpha - A Family of Exposure Systems Suitable for Nebulized Solutions and Suspensions

Poster LIVe 2021 Kongress, 15th June 2021

Patrick Weindl, Heidi Ortolf-Wahl, Tobias Krebs

VITROCELL Systems GmbH, 79183 Waldkirch, Germany

 

Optimal Solution for Everyday Experiments  at the Air/Liquid Interface
The VITROCELL® Cloud Alpha series is our newest innovation and presents a great leap forward in automated exposure of cell cultures. It combines reliable exposure of cell cultures from the respiratory tract with ease of use. The series comprises the Cloud Alpha 6, - 12, - 96 and Cloud Alpha MAX – they represent an optimal solution for everyday experiments at the Air/Liquid Interface using 6-well, 12-well, 24-well or 96-sized inserts. We have run extensive tests to ensure the Cloud Alpha series devices match our standards in terms of the established characteristics for Cloud principle exposure devices: Deposition Efficiency, Spatial Deposition and Repeatability.
 

Read more

Comments (0) Number of views (11)

20. Apr. 2021

An In Vitro Air-Liquid Interface Inhalation Platform for Petroleum Substances and Constituents

DOI: 10.14573/altex.2010211 


Sandra Verstraelen1, An Jacobs1, Jo Van Laer1, Karen Hollanders1, Masha Van Deun2, Diane Bertels2, Rob Brabers1, Hilda Witters1, Sylvie Remy1,3, Lieve Geerts1, Lize Deferme4 and Evelien Frijns1
1VITO NV (Flemish Institute for Technological Research), Unit HEALTH, Mol, Belgium; 
2VITO NV, Unit Separation and Conversion Technology (SCT), Mol, Belgium; 
3University of Antwerp, Department of Biomedical Sciences, Antwerp, Belgium; 
4ExxonMobil Petroleum and Chemical BV, Machelen, Belgium
 

This pilot study exposed a frequently used in vitro model (A549 cells) at the ALI to assess inhalation toxicity of the single compound EB. Experimental conditions using the VITROCELL® 24/48 exposure system were optimized to achieve a (low) delivery efficiency that resulted in dose-dependent biological changes. The data demonstrate consistency in effect levels when comparing cell viability in the ALI experiments with known in vivo non-lethal effects in humans. It can be concluded that QIVIVE from in vitro air concentrations applied for testing cell viability to in vivo air concentrations may be a promising method for screening for acute inhalation toxicity. 

 

Read more

Comments (0) Number of views (74)

23. Feb. 2021

Product News 02/2021

The New VITROCELL® RH/T-Controller

Reliable digital Humidity- and Temperature Measurement

The VITROCELL® RH/T-Controller system was designed to measure temperature and relative humidity in numerous applications at high precision. It can be fitted to humidification systems, aerosol ducts and climatic chambers.

VITROCELL® RH/T-Controller – Reliable digital Humidity- and Temperature Measurement

 

Read more

Comments (0) Number of views (612)

29. Jan. 2021

A Bioinspired in vitro Lung Model to Study Particokinetics of Nano-/Microparticles Under Cyclic Stretch and Air-Liquid Interface Conditions

DOI: 10.3389/fbioe.2021.616830 


Ali Doryab 1,2, Mehmet Berat Taskin 3, Philipp Stahlhut 3, Andreas Schröppel 1,2, Sezer Orak 1,2, Carola Voss 1,2, Arti Ahluwalia 4,5, Markus Rehberg 1,2, Anne Hilgendorff 1,2,6, Tobias Stöger 1,2, Jürgen Groll 3 and Otmar Schmid 1,2

1 Comprehensive Pneumology Center Munich, Member of the German Center for Lung Research, Munich, Germany,
2 Helmholtz Zentrum München—German Research Center for Environmental Health, Institute of Lung Biology and Disease, Munich, Germany, 
3 Department of Functional Materials in Medicine and Dentistry, Bavarian Polymer Institute, University of Würzburg, Würzburg, Germany, 
4 Research Center “E. Piaggio”, University of Pisa, Pisa, Italy, 
5 Department of Information Engineering, University of Pisa, Pisa, Italy, 
6 Center for Comprehensive Developmental Care (CDeCLMU), Dr. von Haunersches Children’s Hospital University, Hospital of the Ludwig-Maximilians University, Munich, Germany
 

We have recently introduced a novel porous and elastic membrane for in vitro cell-stretch models of the lung cultured under ALI conditions (Doryab et al., 2020). This innovative hybrid biphasic membrane, henceforth referred to as Biphasic Elastic Thin for Air-liquid culture conditions (BETA) membrane, was developed to optimize membrane characteristics for  the two phases of cell-stretch experiments under ALI conditions, namely the initial cell seeding, attachment and growth phase under submerged cell culture conditions  (phase  I)  followed  by an ALI acclimatization and cell-stretch phase at the ALI (phase II). This patented aerosol-cell exposure unit has recently been made  commercially  available  as  VITROCELL® Cloud  MAX.

 

Read more

Comments (0) Number of views (73)

22. Jan. 2021

Product News 01/2021

The New VITROCELL® Cloud Alpha MAX

Smallest nebulization volumes and high deposition efficiency

The VITROCELL® Cloud Alpha MAX is designed for small nebulization volumes and very high deposition efficiency. This is important when only small quantities of material are available or when expensive test substances need to be tested.

VITROCELL® Cloud Alpha MAX – Ideal for small quantities of test substance

 

Read more

Comments (0) Number of views (366)

29. Dec. 2020

Air–Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects

https://doi.org/10.3390/nano11010065

 

Silvia Diabaté 1, Lucie Armand 2, Sivakumar Murugadoss 1 , Marco Dilger 1 , Susanne Fritsch-Decker 1, Christoph Schlager 3, David Béal 2, Marie-Edith Arnal 2, Mathilde Biola-Clier 2, Selina Ambrose 4, Sonja Mülhopt 3, Hanns-Rudolf Paur 3, Iseult Lynch 5 , Eugenia Valsami-Jones 5 , Marie Carriere 2, and Carsten Weiss 1

1 Karlsruhe Institute of Technology, Institute of Biological and Chemical Systems–Biological Information Processing, 76344 Eggenstein-Leopoldshafen, Germany;
2 CEA, CNRS, IRIG, SyMMES, University Grenoble Alpes, 38054 Grenoble, France;
3 Karlsruhe Institute of Technology, Institute for Technical Chemistry, 76344 Eggenstein-Leopoldshafen, Germany; 
4 Promethean Particles Ltd., Nottingham NG7 3EF, UK;
5 School of Geography Earth & Environmental Sciences (GEES), University of Birmingham (UoB), Edgbaston, Birmingham B15 2TT, UK;

 

KIT, together with VITROCELL SYSTEMS, set up a first Automated Exposure Station, which has been used for the assessment of nanoscale particle emissions from combustion sources such as ship diesel and wood burners. The system was further developed and offers a compact solution for toxicity testing of nanoparticle (NP) aerosols including sample conditioning, reproducible deposition, integrated dose determination by a quartz crystal microbalance (QCM), flow control, automated processes and data acquisition. The device was also tested with partner laboratories with the aim of potentially standardizing and achieving regulatory acceptance of the method.

 

Read more

Comments (0) Number of views (215)
RSS
12345678910Last
Back to Top